vs
Side-by-side financial comparison of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) and Neptune Insurance Holdings Inc. (NP). Click either name above to swap in a different company.
Neptune Insurance Holdings Inc. is the larger business by last-quarter revenue ($37.8M vs $32.6M, roughly 1.2× ASCENTAGE PHARMA GROUP INTERNATIONAL).
Ascentage Pharma Group International is a global clinical-stage biotechnology company specializing in developing novel targeted therapies for cancers, chronic viral infections, and age-related diseases. It focuses on small molecule drugs targeting apoptosis pathways and other key oncogenic mechanisms, with operations spanning China, the U.S., and other global markets, serving patients with unmet medical needs worldwide.
Neptune Insurance Holdings Inc. is a specialty insurance holding company that offers a broad portfolio of property and casualty insurance products, with a core focus on residential and commercial flood insurance for customers across the United States. It serves both individual consumers and small to mid-sized business clients, using advanced data analytics to support accurate policy pricing and robust risk management.
AAPG vs NP — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $32.6M | $37.8M |
| Net Profit | $11.4M | $50.0K |
| Gross Margin | 90.7% | — |
| Operating Margin | — | — |
| Net Margin | — | 0.1% |
| Revenue YoY | — | 28.8% |
| Net Profit YoY | — | 0.0% |
| EPS (diluted) | — | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $37.8M | ||
| Q3 25 | — | $44.4M | ||
| Q2 25 | $32.6M | — | ||
| Q3 24 | — | $33.8M |
| Q1 26 | — | $50.0K | ||
| Q3 25 | — | $11.5M | ||
| Q2 25 | $11.4M | — | ||
| Q3 24 | — | $12.1M |
| Q1 26 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 90.7% | — | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q3 25 | — | 46.7% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | 58.6% |
| Q1 26 | — | 0.1% | ||
| Q3 25 | — | 25.9% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | 35.8% |
| Q1 26 | — | $0.05 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $0.06 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAPG
| Products | $29.7M | 91% |
| Others | $2.9M | 9% |
NP
Segment breakdown not available.
